We found that VILIP3 was able to activate the Nrf2 signaling pathway in AD models and effectively reduced the levels of oxidative stress and apoptosis by upregulating the expression of antioxidant response element (ARE)-related genes (NQO1, HO-1, GCLC). Here, GCLC is linked to Alzheimer disease.